# Lars Lindholm

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lars-lindholm/

## Facts

| Field | Value |
| --- | --- |
| Citations | 35,589 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 66 |
| i10-index | 258 |
| Last Known Institution | Umeå University |
| OpenAlex ID | https://openalex.org/A5019500608 |
| ORCID iD | 0000-0002-1633-2179 |
| Works | 499 |

## Researcher papers

Showing 12 of 13.

- [Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol](https://scholariq.org/papers/cardiovascular-morbidity-and-mortality-in-the-losartan-intervention-for-endpoint/)
- [2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)](https://scholariq.org/papers/2007-guidelines-for-the-management-of-arterial-hypertension-the-task-force-for/)
- [Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial](https://scholariq.org/papers/effect-of-angiotensin-converting-enzyme-inhibition-compared-with-conventional/)
- [Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)](https://scholariq.org/papers/morbidity-and-mortality-in-the-swedish-trial-in-old-patients-with-hypertension/)
- [Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol](https://scholariq.org/papers/cardiovascular-morbidity-and-mortality-in-patients-with-diabetes-in-the-losartan/)
- [Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study](https://scholariq.org/papers/randomised-trial-of-old-and-new-antihypertensive-drugs-in-elderly-patients/)
- [Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis](https://scholariq.org/papers/pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of/)
- [Clinical Practice Guidelines for the Management of Hypertension in the Community](https://scholariq.org/papers/clinical-practice-guidelines-for-the-management-of-hypertension-in-the-community-2/)
- [Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis](https://scholariq.org/papers/should-blockers-remain-first-choice-in-the-treatment-of-primary-hypertension-a/)
- [Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study](https://scholariq.org/papers/randomised-trial-of-effects-of-calcium-antagonists-compared-with-diuretics-and/)
- [Clinical Practice Guidelines for the Management of Hypertension in the Community](https://scholariq.org/papers/clinical-practice-guidelines-for-the-management-of-hypertension-in-the-community/)
- [Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis](https://scholariq.org/papers/age-stratified-and-blood-pressure-stratified-effects-of-blood-pressure-lowering/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Global Maternal and Child Health](https://scholariq.org/topics/global-maternal-and-child-health/)
- [Global Health Care Issues](https://scholariq.org/topics/global-health-care-issues/)

## Researcher university

- [Umeå University](https://scholariq.org/institutions/umea-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.